Fusion Symposium 2019

FUSION: A unique event for innovative leaders

Harvard’s FUSION symposium integrates perspectives from science and business to explore the promise of an emerging field. This annual, invite-only event brings together entrepreneurs, scientists, business leaders, investors, and innovators for a half-day of exploration and networking. The FUSION symposium is jointly hosted by the Blavatnik Biomedical Accelerator (a program of Harvard University's Office of Technology Development) and by the Blavatnik Fellowship in Life Science Entrepreneurship at Harvard Business School.

The fourth FUSION symposium will address The Science and Business of Cell and Gene Therapy. For more information, contact fusion@harvard.edu.

FUSION 2019: The Science and Business of Aging

Harvard alumnus Sachin H. Jain is seated with other speakers at the 2019 Fusion symposium. Image credit Russ Campbell.

Cover of a report recounting highlights from the 2019 Fusion symposium.

FUSION 2019 Recap

While the medical, scientific, and economic challenges related to aging are immense, many scientific and business leaders are engaged and are focused on practical, scalable, innovative solutions. Some solutions already exist, and others aren’t far off. Read the FUSION 2019 Summary

Featured Speakers

Sachin H. Jain '02, MD'06, MBA '07

President and Chief Executive Officer, CareMore Health System

Watch Sachin's video

Richard J. Hodes, MD '69

Director of the National Institute on Aging at the National Institutes of Health

Watch Richard's video

George Church, PhD '84

Robert Winthrop Professor of Genetics, Blavatnik Institute at Harvard Medical School

Watch George's video

Elli Kaplan, MBA '05

Co-founder and Chief Executive Officer, Neurotrack

Watch Elli's video

Nir Barzilai, MD

Professor of Medicine and of Genetics, Albert Einstein College of Medicine; Director of the Institute for Aging Research, Director of the Paul F. Glenn Center for the Biology of Human Aging Research, and Director of the NIH Nathan Shock Centers of Excellence in the Basic Biology of Aging

Watch Nir's video

Nitin Nohria, Dean of HBS, speaks at the 2019 Fusion symposium. Image credit Russ Campbell.

In many ways, this has proven to be more spectacular than anything that we might have imagined.

Nitin Nohria
Dean, Harvard Business School

ADDITIONAL REMARKS:

Lawrence S. Bacow

President of Harvard University

Nitin Nohria

Dean of Harvard Business School

Michelle A. Williams

Dean of Harvard T.H. Chan School of Public Health

George Q. Daley

Dean of Harvard Medical School

Len Blavatnik MBA '89

Founder and Chairman, Access Industries

Peter Barrett

Faculty Chair, Blavatnik Fellowship in Life Science Entrepreneurship; Partner, Atlas Venture

Isaac Kohlberg

Senior Associate Provost and Chief Technology Development Officer

Cara Sterling

Director, HBS Health Care Initiative

Harvard Chan School Dean Michelle Williams speaks at the 2019 Fusion symposium. Image credit Russ Campbell.

Global population aging is one of the greatest public health challenges of our time. Aging populations will affect the workforce. They will affect families and education and healthcare policies. They will strain healthcare systems, especially those in low-income communities and countries.

Michelle Williams
Dean, Harvard T.H. Chan School of Public Health

Lending insights to action for the aging world

The inevitable infirmities of aging may not be so certain after all. Though few products on the market today can help turn back the hands of time, that may soon change.